# Unraveling the molecular mechanisms of vimentin interaction with G-quadruplex repeats

**Authors:** Marta Cozzaglio, Nicolò Dal Ponte, Martina Rotondo, Barbara Biondi, Riccardo Rigo, Barbara Spolaore, Claudia Sissi

PMC · DOI: 10.1093/nar/gkag247 · 2026-03-24

## TL;DR

This study explores how vimentin interacts with G-quadruplex DNA structures, revealing structural changes that affect its function and oligomerization.

## Contribution

The study identifies a specific vimentin peptide that binds G-quadruplexes and reveals structural perturbations unique to this interaction.

## Key findings

- G-quadruplex repeats induce structural changes in vimentin, including the exposure of coil-1B and reduced α-helical content.
- Regions like coil-1A and coil-2A are stabilized both during DNA binding and polymerization, suggesting functional overlap.
- A vimentin N-terminal peptide (residues 11–30) specifically binds G-quadruplexes, stabilizing the vimentin–DNA complex.

## Abstract

Vimentin is a cytoskeletal protein that exists as soluble tetramers or polymerized filaments. Its tetrameric form selectively interacts with DNA non-canonical secondary structures called G-quadruplex repeats. Here, we applied optimized experimental conditions to preferentially trap the protein at selected oligomerization states. All of them were analyzed by hydrogen–deuterium exchange mass spectrometry to map the vimentin domains that undergo structural changes upon DNA binding and compare them to those associated with its polymerization. G-quadruplex repeats induced unique perturbations of vimentin structure. Among them, the exposure of coil-1B was the most relevant and it had been associated with a reduction in the protein α-helical content. In addition, few protein structural changes were observed both upon G-quadruplex repeats binding and vimentin polymerization, such as the stabilization of coil-1A and coil-2A. This suggests that DNA complex formation impairs the contribution of these regions to vimentin oligomerization. Finally, a peptide from the protein N-terminal domain (residues 11–30) has been identified as a specific G-quadruplex binder, underscoring its direct role in stabilizing the vimentin–DNA complex. Overall, these findings provide detailed insights into the molecular mechanisms that allow DNA to finely modulate the composite structural equilibrium of vimentin and, accordingly, its functions at nuclear level.

Graphical Abstract

## Linked entities

- **Proteins:** PRELID1 (PRELI domain containing 1)

## Full-text entities

- **Genes:** NUCLEOLIN (nucleolin multifunctional protein) [NCBI Gene 4691] {aka C23, NCL, Nsr1}, HDX (highly divergent homeobox) [NCBI Gene 139324] {aka CXorf43, D030011N01Rik}, POT1 (protection of telomeres 1) [NCBI Gene 25913] {aka CMM10, CRMCC3, GLM9, HPOT1, PFBMFT8, TPDS3}, IGKV3D-20 (immunoglobulin kappa variable 3D-20) [NCBI Gene 28874] {aka A11, A11a, IGKV3D20}, ACIN1 (apoptotic chromatin condensation inducer 1) [NCBI Gene 22985] {aka ACINUS, ACN, fSAP152}, VIM (vimentin) [NCBI Gene 7431], DHX36 (DEAH-box helicase 36) [NCBI Gene 170506] {aka DDX36, G4R1, MLEL1, RHAU}, Xrcc5 (X-ray repair complementing 5) [NCBI Gene 22596] {aka CTC85, CTCBF, Ku80, Ku86, Kup80}, Vim (vimentin) [NCBI Gene 22352], HNRNPA1 (heterogeneous nuclear ribonucleoprotein A1) [NCBI Gene 3178] {aka ALS19, ALS20, HNRPA1, HNRPA1L3, IBMPFD3, MPD3}, ETV6 (ETS variant transcription factor 6) [NCBI Gene 2120] {aka TEL, TEL/ABL, THC5}
- **Diseases:** cancer (MESH:D009369), metastatic (MESH:D000092182), metastasis (MESH:D009362)
- **Chemicals:** piperidine (MESH:C032727), DKP (MESH:D054659), acetonitrile (MESH:C032159), amino acid (MESH:D000596), peptide (MESH:D010455), DMF (MESH:C031179), salt (MESH:D012492), methylamine tungstate (MESH:C070810), ice (MESH:D007053), Tween 20 (MESH:D011136), Rh (MESH:D012238), oligonucleotide (MESH:D009841), NaCl (MESH:D012965), guanine (MESH:D006147), urea (MESH:D014508), nitrogen (MESH:D009584), formic acid (MESH:C030544), copper (MESH:D003300), DTT (MESH:D004229), H2O (MESH:D014867), isopropanol (MESH:D019840), glycine (MESH:D005998), Fmoc (-), EGTA (MESH:D004533), TFA (MESH:D014269), PVDF (MESH:C024865), Hydrogen (MESH:D006859), D2O (MESH:D017666), PMSF (MESH:D010664), KCl (MESH:D011189), carbon (MESH:D002244), 2,2,2-trifluoroethanol (MESH:D014270), Triton X-100 (MESH:D017830), Fmoc-amino acid (MESH:C016456), SDS (MESH:D012967), MgCl2 (MESH:D015636), guanidine-HCl (MESH:D019791), Dabcyl (MESH:C063127), NaOH (MESH:D012972), deuterium (MESH:D003903), EDTA (MESH:D004492), potassium (MESH:D011188)
- **Species:** Escherichia coli (E. coli, species) [taxon 562], Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Mutations:** S5G, F200X, C-95 C, C-90 C, C (A) for 10, arginine-glycine, 5 C
- **Cell lines:** VIM-2TEL — Mus musculus (Mouse), Spontaneously immortalized cell line (CVCL_JZ63), VIM-G4rp — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_B2L2), BL21(DE3) — Mus musculus (Mouse), Hybridoma (CVCL_B7HM)

## Figures

8 figures with captions in the complete paper: https://tomesphere.com/paper/PMC13010136/full.md

---
Source: https://tomesphere.com/paper/PMC13010136